The sudden resignation of Dr. Peter Marks, the head of the FDA’s Center for Biologics Evaluation and Research, has sent shockwaves through the pharmaceutical and biotech industries. Dr. Marks, a central figure in the U.S. vaccine rollout during the COVID-19 pandemic,...